JACLYN WEBER: Open Payments
NPI 1992371702 · NEW BOSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $44 |
| Boston Scientific Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, WATCHMAN FLX, SHINGRIX, Cologuard Collection Kit, SEROQUEL, VRAYLAR, OPSUMIT, Wegovy.
Industry payments across MI — which companies pay providers there.
